KB

Kamal Bablani

Active Director Director DIN 00422894
DIN 00422894 First appointment Oct 2004 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamal Bablani

Data last updated:

Kamal Bablani is a Director at Aryave Biotech Private Limited (since 2004). The company operates in Life Sciences.

DIN 00422894
Primary Designation Director
Industry Life Sciences
First Appointment 15 Oct 2004
Oldest Company Age 22 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aryave Biotech Private Limited U01122DL2004PTC129990
Director15 Oct 20042004Active

Board colleagues of Kamal Bablani

NameDINCompanyDesignation
Kumud Bablani00457671Aryave Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aryave Biotech Private Limited
Premium access

Shareholding and investment profile for Kamal Bablani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Bablani

Kamal Bablani currently holds 1 directorship: Aryave Biotech Private Limited (Director, since 15 Oct 2004).

Kamal Bablani was first appointed on 15 Oct 2004 as Director at Aryave Biotech Private Limited.

The current boards of Kamal Bablani's companies include Kumud Bablani (Aryave Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available